Your browser doesn't support javascript.
loading
Survivors of infant atypical teratoid/rhabdoid tumors present with severely impaired cognitive functions especially for fluid intelligence and visual processing: data from the German brain tumor studies.
Traunwieser, Thomas; Loos, Elena; Ottensmeier, Holger; Gastberger, Katharina; Nemes, Karolina; Mynarek, Martin; Bison, Brigitte; Kandels, Daniela; Neumayer, Petra; Neumann-Holbeck, Anne; Lüttich, Peggy; Baust, Katja; Faulstich-Ritter, Kristin; John, Rainer; Kreisch, Andrea; Landmann, Judyta; Manteufel, Eva; Nest, Alexandra; Prüfe, Jenny; Schubert, Lisa; Stamm, Walther; Timmermann, Beate; Gerss, Joachim; Rutkowski, Stefan; Schlegel, Paul-Gerhardt; Eyrich, Matthias; Gnekow, Astrid K; Frühwald, Michael C.
Affiliation
  • Traunwieser T; Swabian Children's Cancer Center, Pediatrics and Adolescent Medicine, University Hospital Augsburg, Augsburg, Germany.
  • Loos E; Bavarian Cancer Research Center, Augsburg, Germany.
  • Ottensmeier H; Swabian Children's Cancer Center, Pediatrics and Adolescent Medicine, University Hospital Augsburg, Augsburg, Germany.
  • Gastberger K; Bavarian Cancer Research Center, Augsburg, Germany.
  • Nemes K; Department of Pediatric Hematology and Oncology, University Hospital Würzburg, Würzburg, Germany.
  • Mynarek M; Swabian Children's Cancer Center, Pediatrics and Adolescent Medicine, University Hospital Augsburg, Augsburg, Germany.
  • Bison B; Bavarian Cancer Research Center, Augsburg, Germany.
  • Kandels D; Swabian Children's Cancer Center, Pediatrics and Adolescent Medicine, University Hospital Augsburg, Augsburg, Germany.
  • Neumayer P; Bavarian Cancer Research Center, Augsburg, Germany.
  • Neumann-Holbeck A; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany.
  • Lüttich P; Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Baust K; Diagnostic and Interventional Neuroradiology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
  • Faulstich-Ritter K; Neuroradiological Reference Center for the Pediatric Brain Tumor (HIT) Studies of the German Society of Pediatric Oncology and Hematology, Faculty of Medicine, University Augsburg, Augsburg, Germany.
  • John R; Swabian Children's Cancer Center, Pediatrics and Adolescent Medicine, University Hospital Augsburg, Augsburg, Germany.
  • Kreisch A; Bavarian Cancer Research Center, Augsburg, Germany.
  • Landmann J; Swabian Children's Cancer Center, Pediatrics and Adolescent Medicine, University Hospital Augsburg, Augsburg, Germany.
  • Manteufel E; Bavarian Cancer Research Center, Augsburg, Germany.
  • Nest A; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany.
  • Prüfe J; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg, University Hospital, Heidelberg, Germany.
  • Schubert L; Department of Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany.
  • Stamm W; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
  • Timmermann B; Department Pediatric Hematology and Oncology, Center for Chronically Sick Children (SPZ), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Gerss J; Department of Pediatrics, University Hospital and Medical Faculty Carl-Gustav-Carus, Technische Universität Dresden, Dresden, Germany.
  • Rutkowski S; Department of Paediatric Haematology and Oncology, Hannover Medical School, Hannover, Germany.
  • Schlegel PG; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Justus-Liebig University of Giessen, Giessen, Germany.
  • Eyrich M; Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany.
  • Gnekow AK; Department of Pediatric Hematology and Oncology, Pediatrics III, Essen University Hospital, Essen, Germany.
  • Frühwald MC; Department of Pediatric Hematology and Oncology, University Hospital Würzburg, Würzburg, Germany.
Pediatr Blood Cancer ; 71(5): e30910, 2024 May.
Article de En | MEDLINE | ID: mdl-38342954
ABSTRACT

BACKGROUND:

The contribution of tumor type, multimodal treatment, and other patient-related factors upon long-term cognitive sequelae in infant brain tumor survivors remains undefined. We add our retrospective analysis of neuropsychological and quality of survival (QoS) outcome data of survivors of atypical teratoid/rhabdoid tumors (ATRT) and extracranial malignant rhabdoid tumors of the soft tissues (eMRT) and kidneys (RTK) treated within the same framework. Neuropsychological data from children with ATRT were compared to data from children with non-irradiated low-grade glioma (LGG). PATIENTS AND

METHODS:

Following surgery, patients (0-36 months at diagnosis) had received radio-chemotherapy (up to 54 Gy; ATRT n = 13; eMRT/RTK n = 7), chemotherapy only (LGG n = 4; eMRT/RTK n = 1) or had been observed (LGG n = 11). Neuropsychological evaluation employing comparable tests was performed at median 6.8 years (ATRT), 6.6 years (eMRT/RTK), and 5.2 years (LGG) post diagnosis.

RESULTS:

We detected sequelae in various domains for all tumor types. Group comparison showed impairments, specifically in fluid intelligence (p = .041; d = 1.11) and visual processing (p = .001; d = 2.09) in ATRT patients when compared to LGG patients. Results for psychomotor speed and attention abilities were significantly below the norm for both groups (p < .001-.019; d = 0.79-1.90). Diagnosis predicted impairments of cognitive outcome, while sex- and age-related variables did not. QoS outcome for all rhabdoid patients displayed impairments mainly in social (p = .008; d = 0.74) and school functioning (p = .048; d = 0.67), as well as lower overall scores in psychosocial functioning (p = .023; d = 0.78) and quality of life (p = .006; d = 0.79) compared to healthy controls.

CONCLUSION:

Survivors of infant ATRT experience various late effects in cognition and QoS following multimodal treatment, while infant LGG patients without radiotherapy demonstrated comparable impairments in psychomotor and attention abilities. Early onset and multimodal treatment of rhabdoid tumors require close monitoring of neuropsychological and QoS sequelae.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tératome / Tumeurs du cerveau / Tumeurs du système nerveux central / Tumeur rhabdoïde / Tumeurs neuroépitheliales / Gliome Type d'étude: Prognostic_studies Aspects: Patient_preference Limites: Child / Humans / Infant Langue: En Journal: Pediatr Blood Cancer Sujet du journal: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Année: 2024 Type de document: Article Pays d'affiliation: Allemagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tératome / Tumeurs du cerveau / Tumeurs du système nerveux central / Tumeur rhabdoïde / Tumeurs neuroépitheliales / Gliome Type d'étude: Prognostic_studies Aspects: Patient_preference Limites: Child / Humans / Infant Langue: En Journal: Pediatr Blood Cancer Sujet du journal: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Année: 2024 Type de document: Article Pays d'affiliation: Allemagne